Balla
Chandrasekhar
,
Sudhakar
Athe
,
P. Purushotham
Reddy
and
Subhash
Ghosh
*
Organic and Biomolecular Chemistry Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, India. E-mail: subhash@iict.res.in; Fax: +914027193275, +914027193108; Tel: +914027191604
First published on 1st October 2014
This article reported the synthesis of fully functionalized aglycone of lycoperdinoside A and B. Pd-catalyzed Stille–Migita cross coupling between E-vinyl iodide 6 and E-vinyl stannane 23 established the highly substituted E,E-diene unit present in lycoperdinoside A and B. The other two Z-olefins present in the molecule were introduced by means of cis-selective Horner–Wadsworth–Emmons reaction with Still–Gennari phosphonate. Evans syn- and anti-aldol reactions were utilized to fix six of the seven stereo centres present in the aglycone.
For the synthesis of fragment 5, compound 12 was prepared from compound 8 according to the reported procedure.6 Oxidation of the primary alcohol 12 under Swern conditions gave an aldehyde, which was subjected to Evans syn aldol reaction to provide compound 13 in 82% yield over two steps. Protection of the secondary alcohol with TBSOTf followed by removal of chiral auxiliary furnished alcohol 14 in 72% yield over two steps. Oxidation of the alcohol 14 followed by the Wittig reaction of the resulting aldehyde with two carbon stable ylide Ph3PCHCOOEt afforded α,β-unsaturated ester 15 (E:Z = 98:2) in 80% yield over two steps. Reductions of the olefin as well as ester functional groups were carried out with LiBH4 to give primary alcohol 16 in 84% yield. TBS protection of the primary alcohol followed by debenzylation under hydrogenolysis conditions furnished primary alcohol 18 in 73% yield over two steps. Oxidation of the primary alcohol 18 with DMP gave an aldehyde which was subjected to Corey–Fuchs reaction7 to afford the alkyne compound 7 in 72% yield over three steps. Finally methylation of the alkyne compound 7 with BuLi, MeI and selective cleavage of the primary TBS ether with HF·Py provided the crucial intermediate 19 in 83% yield over two steps. Selectively primary TBS ether of 7 was cleaved at this stage with the thought that the stannane compound 5 will be polar, and will facilitate its separation from a highly non-polar unreacted stannane reactant. With the alkyne compound 19 in our hand, the stage was set for the crucial stannylation reaction. Accordingly compound 19 was subjected to stannylation under different conditions8 (Table 1) to provide the required stannane, however despite our best efforts we did not get the desired product 5 (Scheme 2).
Scheme 2 Reagents and conditions: (i) (a) (COCl)2, DMSO, Et3N, CH2Cl2, −78 °C to 0 °C, 1 h; (b) (S)-4-benzyl-3-propionyloxazolidin-2-one, Bu2BOTf, DIPEA, 0 °C, then aldehyde, −78 °C, 2.5 h, 82%; (ii) (a) TBSOTf, 2,6-lutidine, CH2Cl2, 0 °C–rt, 24 h; (b) NaBH4, THF–H2O (5:1), 10 h, 72% over two steps; (iii) (a) DMP, CH2Cl2, 0 °C-rt, 1 h; (b) Ph3PCHCOOEt, C6H6, 90 °C, 1.5 h, 80%; (iv) LiBH4, THF, 0 °C–rt, 48 h, 84%; (v) TBSOTf, 2,6-lutidine, CH2Cl2, 0 °C-rt, 30 min, 86%; (vi) H2/Pd–C, EtOAc, 5 h, 85%; (vii) (a) DMP, CH2Cl2, 0 °C–rt, 1 h; (b) PPh3, CBr4, Et3N, CH2Cl2, 0 °C, 2.5 h; (c) n-BuLi, THF, −78 °C to 0 °C, 1 h, 72% over three steps; (viii) (a) n-BuLi, MeI, THF, −78 °C to 0 °C, 1 h; (b) HF·Py, THF, 0 °C–rt, 6 h, 83% over two steps; (ix) see Table 1. |
Entry | Conditions | Yield |
---|---|---|
1 | PdCl2(PPh3)2, Bu3SnH, THF, rt | Traces |
2 | Bu3Sn(Bu)CuLi·LiCN, THF, MeOH, −78 °C to −10 °C | — |
3 | Bu3SnH, AIBN, Toluene, 80 °C | Traces |
This failure of stannylation forced us to develop an alternate strategy as shown in Scheme 3. In 2002, Marshall et al.9 reported that the electron withdrawing group like the –CH2OAc substituent at the terminal position facilitates the stannylation at the C-2 position. With this report, we thought that the stannylation reaction at the C2 position can be facilitated in a substrate like 22 and the CH2OAc can be converted to CH3 at the later stage of the synthesis. With this plan the alkyne 7 was reacted with HCHO in the presence of BuLi to furnish compound 20 which on acetylation afforded compound 21 in 72% yield over two steps. Selectively TBS ether of the primary alcohol was cleaved at this stage with HF·Py to give polar compound 22. Compound 22 on treatment with Bu3SnH in the presence of Pd(PPh3)2Cl2 in THF furnished chromatographically pure stannane compound 23 in 68% yield.
Next we turn our attention for the synthesis of vinyl iodide 6. The Evans alkylation reaction10 with the known iodide 1111 furnished compound 24 (dr = 92:8) in 51% yield over three steps, which on reaction with NaBH4 in THF–H2O afforded known primary alcohol 1012 in 85%. Oxidation of alcohol 10 with DMP gave an aldehyde, which on cis selective Horner–Wadsworth–Emmons reaction with Still–Gennari phosphonate furnished compound 25 (Z:E = 95:5) in 75% over two steps. DIBAL-H reduction13 of 25 afforded allylic alcohol 26, which on oxidation followed by magnesium chloride catalysed anti aldol reaction under Evans protocol furnished compound 27 in 59% yield over three steps. Protection of the secondary alcohol with TBSOTf followed by the removal of chiral auxiliary from 27 gave primary alcohol 9, which on oxidation followed by the Z-selective HWE reaction afforded compound 28 (Z:E = 93:7) in 53% yield over four steps. Finally acid catalysed TBS group deprotection followed by in situ lactonization completed the synthesis of vinyl iodide fragment 6 (Scheme 4).
Having both the fragments in hand, the crucial Pd-catalyzed Stille coupling14 between 23 and 6 was tried under different reaction conditions (Table 2). The best result was obtained when the coupling reaction was carried out under Stille–Migita cross coupling conditions15 using the combination of catalytic amounts of Pd(PPh3)4, copper thiophene-2-carboxylate (CuTC)16 and [Ph2PO2][NBu4]17 in a THF and DMF mixture to give compound 29 in 45% yield (Scheme 5). The geometry of the newly formed diene unit in 29 was confirmed by NOE studies.18 Finally, two-step oxidation of the primary alcohol followed by esterification of the resulting acid completed the synthesis of C1–C21 aglycone 30, of lycoperdinoside A and B.
Scheme 5 Reagents and conditions: (i) (a) see Table 2, (ii) (a) DMP, CH2Cl2, 0 °C–rt, (b) NaClO2, NaH2PO4, t-BuOH:H2O, 2-methyl-2-butene, 0 °C–rt, 1 h; (c) CH2N2, Et2O, 0 °C, 30 min, 70% over three steps. |
Entry | Catalyst (10 mol%) | Conditions | Yield |
---|---|---|---|
1 | Pd(CH3CN)2Cl2 | LiCl, Hunig's base, DMF, rt, 10 h | 10% |
2 | Pd(PPh3)4 | CuTC, DMF, THF, rt, 10 h | 20% |
3 | Pd(PPh3)4 | CuTC, [Ph2PO2][NBu4], DMF, THF, rt, 4 h | 45% |
Di-n-butylborontriflate (1 M in CH2Cl2, 17.7 mL, 17.72 mmol) was added to a solution of (S)-4-benzyl-3-propionyloxazolidin-2-one (3.79 g, 16.24 mmol) in CH2Cl2 (40 mL) at 0 °C under a nitrogen atmosphere, followed by the addition of DIPEA (3.34 mL, 19.2 mmol). After stirring at 0 °C for 1 h, a solution of the above aldehyde in CH2Cl2 (10 mL, 2×) was added at −78 °C. The resulting pale yellow solution was stirred at −78 °C for 1.5 h and at 0 °C for 30 minutes. The reaction mixture was quenched at 0 °C with phosphate buffer (pH = 7, 21 mL) followed by MeOH (75 mL), resulting in a homogeneous solution. After 5 min, 21 mL of 30% aqueous H2O2 in MeOH (30 mL) was added over a period of 30 min. After stirring at 0 °C for 1 h, the solvent was removed by rotary evaporation and the resulting residual oil was extracted with EtOAc (2 × 100 mL). The combined organic extracts were washed with saturated aqueous NaHCO3 (50 mL), water (50 mL), saturated aqueous NaCl (50 mL) and dried over Na2SO4. Evaporation of the solvent under reduced pressure furnished the crude product which on purification via column chromatography (silica gel, 15% EtOAc in petroleum ether as an eluent) provided the aldol product 13 (6.89 g, 82%) as a colourless liquid.
R f = 0.5 (SiO2, 30% EtOAc in petroleum ether); [α]24D = +14.52 (c 1.37, CHCl3); IR νmax 3456, 2929, 2856, 2363, 2333, 1778, 1703, 1458, 1384, 1206, 1103, 836, 770, 741, 700 cm−1; 1H NMR (300 MHz, CDCl3) δ 7.29–7.18 (m, 10H), 4.62 (m, 1H), 4.49 (d, J = 12.0 Hz, 1H), 4.41 (d, J = 12.0 Hz, 1H), 4.18–4.09 (m, 3H), 3.97–3.88 (m, 2H), 3.80 (qd, J = 6.8, 1.5 Hz, 1H), 3.48 (dd, J = 5.4, 6.6 Hz, 2H), 3.35 (dd, J = 13.2, 2.6 Hz, 1H), 2.70 (dd, J = 13.0, 10.0 Hz, 1H), 1.92–1.72 (m, 3H), 1.18 (d, J = 6.7 Hz, 3H), 0.88 (s, 9H), 0.85 (d, J = 7.1 Hz, 3H), 0.11 (s, 3H), 0.06 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 175.8, 153.1, 138.3, 135.4, 129.4(2), 128.9(2), 128.3(2), 127.6(2), 127.5, 127.2, 73.4, 73.0, 72.8, 66.9, 66.1, 55.8, 40.6, 39.8, 37.7, 32.0, 25.8, 17.9, 12.3, 8.3, −4.5, −5.0; MS (ESI) m/z 570 [M + H]+, 592 [M + Na]+; HRMS (ESI, QSTAR-TOF) calcd for C32H47O6NSiNa [M + Na]+ 592.3064, found 592.3062.
To a solution of the above TBS protected compound in a mixture of THF and water (5:1) (60 mL) was added NaBH4 (2.19 g, 57.90 mmol) at 0 °C. The reaction mixture was allowed to attain room temperature and stirred overnight. Then the reaction mixture was quenched by the addition of saturated aqueous NH4Cl (20 mL) at 0 °C. The solvent was removed by rotary evaporation and the resulting residual oil was extracted with EtOAc (2 × 100 mL). The combined organic layers were washed with water (50 mL), saturated aqueous NaCl (50 mL), dried (Na2SO4), filtered and concentrated under vacuum. Purification by column chromatography (silica gel, 5–8% EtOAc in the petroleum ether eluent) afforded pure compound 14 (4.26 g, 72% over two steps) as light yellow oil.
R f = 0.45 (SiO2, 10% EtOAc in petroleum ether); [α]24D = −5.33 (c 1.12, CHCl3); IR νmax 3419, 2952, 2929, 2856, 2363, 1463, 1363, 1252, 1079, 1039, 833, 771, 672 cm−1; 1H NMR (300 MHz, CDCl3): δ 7.34–7.25 (m, 5H), 4.48 (ABq, J = 12.8 Hz, 2H), 3.91 (dd, J = 6.0, 1.5 Hz, 1H), 3.84 (q, J = 5.2 Hz, 1H), 3.53–3.38 (m, 4H), 1.96–1.65 (m, 6H), 0.97–0.81 (m, 24H), 0.08–0.04 (m, 12H); 13C NMR (75 MHz, CDCl3): δ 138.4, 128.3, 127.7, 127.5, 73.0, 72.4, 71.3, 66.9, 66.8, 44.0, 38.0, 35.5, 26.0, 25.9, 18.3, 18.2, 11.2, 11.1, −3.6, −3.7, −3.9, −4.5; MS (ESI) m/z 511 [M + H]+, 533 [M + Na]+; HRMS (ESI, QSTAR-TOF) calcd for C28H54O4Si2Na [M + Na]+ 533.3458, found 533.3462.
To the above aldehyde in benzene (25 mL) was added Wittig ylide Ph3PCHCOOEt (4.8 g, 13.7 mmol) at room temperature and heated to reflux at 90 °C. After 1.5 h, the solvent was evaporated in vacuo and the residue was purified by column chromatography (silica gel, 2% EtOAc in the petroleum ether eluent) to afford the pure compound 15 (3.17 g, 80%) as yellow oil.
R f = 0.52 (SiO2, 5% EtOAc in petroleum ether); [α]28D = +10.61 (c 3.16, CHCl3); IR νmax 2953, 2932, 2857, 2363, 1720, 1648, 1464, 1365, 1256, 1180, 1075, 1031, 835, 773 cm−1; 1H NMR (500 MHz, CDCl3): δ 7.34–7.26 (m, 5H), 6.98 (dd, J = 16.0, 7.0 Hz, 1H), 5.78 (d, J = 16.0 Hz, 1H), 4.50 (d, J = 12.0 Hz, 1H), 4.47 (d, J = 12.0 Hz, 1H), 4.21–4.17 (m, 2H), 3.93 (q, J = 5.0 Hz, 1H), 3.71 (dd, J = 6.0, 3.0 Hz, 1H), 3.48 (t, J = 7.0 Hz, 2H), 2.51 (m, 1H), 1.88–1.84 (m, 2H), 1.67 (m, 1H), 1.30–1.27 (m, 3H), 1.04 (d, J = 7.0 Hz, 3H), 0.88 (s, 18H), 0.87 (d, J = 7.0 Hz, 3H), 0.06 (s, 6H), 0.04 (s, 3H), 0.02 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 166.6, 153.6, 138.3, 128.3, 127.6, 127.5, 120.3, 76.5, 73.0, 70.5, 66.9, 60.1, 43.7, 39.6, 35.5, 26.0, 25.9, 18.3, 18.2, 14.2, 13.2, 10.6, −3.6, −3.7, −3.9, −4.1; MS (ESI) m/z 601 [M + Na]+; HRMS (ESI, QSTAR-TOF) calcd for C32H58O5Si2Na [M + Na]+ 601.3715, found 601.3718.
R f = 0.5 (SiO2, 20% EtOAc in petroleum ether); [α]24D = +3.89 (c 0.72, CHCl3); IR νmax 3564, 2931, 2857, 2363, 1515, 1463, 1253, 1056, 835, 772, 739, 697 cm−1; 1H NMR (400 MHz, CDCl3): δ 7.29–7.23 (m, 5H), 4.48 (d, J = 11.7 Hz, 1H), 4.45 (d, J = 11.7 Hz, 1H), 3.91 (q, J = 5.4 Hz, 1H), 3.62–3.55 (m, 3H), 3.45 (t, J = 6.5 Hz, 2H), 1.84–1.78 (m, 2H), 1.65–1.33 (m, 6H), 1.24 (m, 1H), 0.88–0.82 (m, 24H), 0.06–0.02 (m, 12H); 13C NMR (75 MHz, CDCl3): δ 138.4, 128.3, 127.6, 127.5, 76.4, 73.0, 70.8, 67.0, 63.2, 43.7, 35.7, 35.5, 31.3, 30.9, 26.1, 25.9, 18.5, 18.2, 14.0, 11.0, −3.5, −3.6, −3.8, −3.9; MS (ESI) m/z 561 [M + Na]+; HRMS (ESI, QSTAR-TOF) calcd for C30H58O4Si2Na [M + Na]+ 561.3771, found 561.3778.
R f = 0.5 (SiO2, 2% EtOAc in petroleum ether); [α]24D = +2.73 (c 1.13, CHCl3); IR νmax 2931, 2953, 2858, 1465, 1384, 1253, 1101, 836, 774, 670 cm−1; 1H NMR (500 MHz, CDCl3): δ 7.33–7.25 (m, 5H), 4.50 (d, J = 11.9 Hz, 1H), 4.47 (d, J = 11.9 Hz, 1H), 3.92 (q, J = 4.9 Hz, 1H), 3.62–3.57 (m, 3H), 3.48 (t, J = 6.9 Hz, 2H), 1.85 (q, J = 6.9 Hz, 2H), 1.64–1.32 (m, 5H), 1.25 (m, 1H), 0.89–0.82 (m, 33H), 0.06, 0.04 and 0.038 (three s, 18H); 13C NMR (125 MHz, CDCl3): δ 138.4, 128.2, 127.6, 127.4, 76.6, 73.0, 70.8, 67.0, 63.5, 43.5, 35.7, 35.6, 31.6, 31.1, 26.1, 25.9(2), 18.5, 18.3, 18.2, 13.8, 10.9, −3.5, −3.6, −3.9(2), −5.3(2); MS (ESI) m/z 653 [M + H]+, 675 [M + Na]+; HRMS (ESI, QSTAR-TOF) calcd for C36H72O4Si3Na [M + Na]+ 675.4636, found 675.4641.
R f = 0.5 (SiO2, 10% EtOAc in petroleum ether); [α]24D = +2.15 (c 0.32, CHCl3); IR νmax 3619, 2931, 2857, 2363, 2332, 1516, 1464, 1252, 1101, 835, 773 cm−1; 1H NMR (400 MHz, CDCl3): δ 3.91 (q, J = 5.4 Hz, 1H), 3.80 (m, 1H), 3.67 (m, 1H), 3.58 (t, J = 6.2 Hz, 3H), 1.89–1.69 (m, 4H), 1.55–1.32 (m, 4H), 1.24 (m, 1H), 0.90 and 0.89 (two s, 30H), 0.86 (d, J = 6.2 Hz, 3H), 0.11 (s, 3H), 0.08 (s, 6H), 0.06 (s, 3H), 0.04 (s, 6H); 13C NMR (75 MHz, CDCl3): δ 76.5, 72.4, 63.4, 59.9, 43.1, 37.2, 35.6, 31.7, 31.1, 26.1(2), 26.0(3), 14.2, 11.9(2), −3.5, −3.7, −4.0, −4.1, −5.2(2); MS (ESI) m/z 563 [M + H]+, 585 [M + Na]+; HRMS (ESI, QSTAR-TOF) calcd for C29H66O4Si3Na [M + Na]+ 585.4166, found 585.4165.
To a solution of CBr4 (412 mg, 1.24 mmol) in dry CH2Cl2 (10 mL) was added PPh3 (651 mg, 2.48 mmol) at 0 °C and this mixture was stirred for 30 min. To the resulting orange-red solution, Et3N (0.86 mL, 6.21 mmol) was added and stirred for 10 min at the same temperature. Aldehyde in CH2Cl2 (3 mL, ×2) was cannulated to the above reaction mixture and stirred for 2.5 h at 0 °C. Then the reaction mixture was poured into the petroleum ether (30 mL). The solvent was decanted from the sticky precipitate and the residue was dissolved again in CH2Cl2 (5 mL). The solution was again poured into petroleum ether (20 mL) and the solvent was again decanted from the sticky precipitate. This procedure was repeated twice. The precipitate was then discarded. The solvent fractions were combined and concentrated in vacuo. The resulting crude product (Rf = 0.80, 5% EtOAc in petroleum ether) was subjected to silica gel column chromatography (silica was basified with 1% Et3N in petroleum ether) (SiO2, 2% EtOAc in the petroleum ether eluent) to provide a pure dibromo compound, as a syrupy liquid. This dibromo compound was used for next step without further characterization.
To a solution of dibromide in dry THF (4 mL) at −78 °C, n-BuLi (1.6 M in hexane, 0.78 mL, 1.25 mmol) was added slowly with stirring under a nitrogen atmosphere. The mixture was slowly warmed to 0 °C and held at this temperature for 1 h. The reaction mixture was then quenched with saturated aqueous NH4Cl (5 mL) and extracted with EtOAc (15 mL). The combined organic extracts were washed with water (5 mL), brine (5 mL), dried (Na2SO4), filtered and concentrated in vacuo. Column chromatography (SiO2, 1% EtOAc in the petroleum ether eluent) gave pure compound 7 (250 mg, 72% over three steps) as a yellow liquid.
R f = 0.5 (SiO2, 2% EtOAc in petroleum ether); [α]26D = +6.47 (c 0.86, CHCl3); IR νmax 2932, 2858, 2362, 1465, 1392, 1253, 1097, 1033, 834, 773 cm−1; 1H NMR (500 MHz, CDCl3): δ 3.92 (q, J = 5.0 Hz, 1H), 3.60–3.58 (m, 3H), 2.39 (dd, J = 5.9, 2.0 Hz, 2H), 2.00–1.95 (m, 2H), 1.58–1.51 (m, 2H), 1.47 (m, 1H), 1.37 (m, 1H), 1.25 (m, 1H), 0.90 and 0.89 (two s, 27H), 0.87 (d, J = 6.9 Hz, 3H), 0.86 (d, J = 6.0 Hz, 3H), 0.09 (s, 6H), 0.08 (s, 3H), 0.06 (s, 3H), 0.05 (s, 6H); 13C NMR (75 MHz, CDCl3): δ 81.4, 77.1, 71.6, 70.3, 63.5, 42.7, 35.9, 31.6, 31.1, 26.2(2), 26.0, 25.9, 18.5, 18.4, 18.2, 14.0, 11.0, −3.5, −3.7, −3.8, −4.2, −5.3(2); MS (ESI) m/z 579 [M + Na]+; HRMS (ESI, QSTAR-TOF) calcd for C30H64O3Si3Na [M + Na]+ 579.4055, found 579.4044.
The above methylated compound dissolved in dry THF (3 mL) was transferred to a plastic container fitted with a magnetic stirrer bar and treated with HF·Py (23 µL) at 0 °C. After stirring for 6 h at room temperature, saturated aqueous NaHCO3 (2 mL) was added to the reaction mixture and extracted with EtOAc (2 × 10 mL). The combined organic extracts were washed with water (10 mL), brine (10 mL), dried (Na2SO4), filtered and concentrated in vacuo. Purification of the residue by column chromatography (SiO2, 10% EtOAc in the petroleum ether eluent) afforded the pure product 19 (68 mg, 83% over two steps) as colourless oil.
R f = 0.5 (SiO2, 15% EtOAc in petroleum ether); [α]24D = +2.0 (c 1.4, CHCl3); IR νmax 3309, 2930, 2857, 1465, 1384, 1252, 1058, 834, 773, 672 cm−1; 1H NMR (500 MHz, CDCl3): δ 3.85 (td, J = 6.1, 3.9 Hz, 1H), 3.63 (t, J = 6.7 Hz, 2H), 3.59 (dd, J = 6.4, 1.7 Hz, 1H), 2.31–2.29 (m, 2H), 1.97 (m, 1H), 1.75 (t, J = 2.4 Hz, 3H), 1.62–1.52 (m, 4H), 1.37 (m, 1H), 1.28 (m, 1H), 0.90 and 0.87 (two s, 18H), 0.87 (d, J = 6.0 Hz, 3H), 0.85 (d, J = 7.1 Hz, 3H), 0.09 (s, 3H), 0.08 (s, 3H), 0.07 (s, 3H), 0.06 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 77.5, 77.0, 76.1, 72.2, 63.4, 42.9, 35.7, 31.6, 31.0, 26.3, 26.1, 25.9, 18.5, 18.2, 14.1, 10.5, 3.5, −3.6, −3.6, −3.8, −4.2; MS (ESI) m/z 457 [M + H]+; HRMS (ESI, QSTAR-TOF) calcd for C25H53O3Si2 [M + H]+ 457.35277, found 457.35467.
R f = 0.5 (SiO2, 20% EtOAc in petroleum ether); [α]24D = +12.11 (c 1.09, CHCl3); IR νmax 3620, 2931, 2858, 2362, 2333, 1465, 1253, 1098, 1030, 834, 774, 671 cm−1; 1H NMR (500 MHz, CDCl3): δ 4.22 (s, 2H), 3.89 (dd, J = 9.9 Hz, 5.9 Hz, 1H), 3.61–3.57 (m, 3H), 2.43–2.42 (m, 2H), 1.94 (m, 1H), 1.59–1.41 (m, 3H), 1.38 (m, 1H), 1.23 (m, 1H), 0.91, 0.90 and 0.89 (three s, 27H), 0.87 (d, J = 7.0 Hz, 3H), 0.86 (d, J = 7.0 Hz, 3H), 0.10, 0.09, 0.08, 0.07 (four s, 12H), 0.05 (s, 6H); 13C NMR (75 MHz, CDCl3): δ 83.4, 80.4, 77.3, 71.7, 63.5, 51.3, 42.8, 36.0, 31.5, 31.1, 26.4, 26.1, 26.0, 25.9, 18.5, 18.3, 18.2, 14.1, 11.2, −3.5, −3.7, −3.8, −4.2, −5.3(2); MS (ESI) m/z 604 [M + NH4]+; HRMS (ESI, QSTAR-TOF) calcd for C31H70O4Si3N [M + NH4]+ 604.4613, found 604.4615.
R f = 0.7 (SiO2, 15% EtOAc in petroleum ether); [α]24D = +2.09 (c 0.96, CHCl3); IR νmax 2928, 2857, 2406, 2363, 1741, 1707, 1647, 1516, 1464, 1252, 1096, 1030, 835, 774 cm−1; 1H NMR (500 MHz, CDCl3): δ 4.64 (s, 2H), 3.91 (q, J = 5.2 Hz, 1H), 3.60–3.56 (m, 3H), 2.41 (br, 2H), 2.07 (s, 3H), 1.91 (m, 1H), 1.49–1.33 (m, 3H), 0.90–0.85 (m, 35H); 0.08–0.04 (m, 18H); 13C NMR (75 MHz, CDCl3): δ 170.3, 84.7, 77.1, 75.8, 71.6, 63.5, 52.8, 43.0, 35.8, 31.6, 31.1, 26.4, 26.1, 26.0, 25.8, 20.8, 18.5, 18.3, 18.1, 13.9, 10.8, −3.6, −3.7, −3.8, −4.2, −5.3(2); MS (ESI) m/z 651 [M + Na]+; HRMS (ESI, QSTAR-TOF) calcd for C33H68O5Si3Na [M + Na]+ 651.4266, found 651.4271.
R f = 0.5 (SiO2, 20% EtOAc in petroleum ether); [α]24D = −6.07 (c 0.89, CHCl3); IR νmax 3565, 2931, 2858, 2363, 2332, 1741, 1693, 1516, 1463, 1030, 835, 773, 670 cm−1; 1H NMR (500 MHz, CDCl3): δ 4.64 (s, 2H), 3.90 (q, J = 5.3 Hz, 1H), 3.63 (t, J = 6.5 Hz, 2H), 3.57 (dd, J = 6.0, 2.0 Hz, 1H), 2.43–2.42 (m, 2H), 2.06 (s, 3H), 1.93 (m, 1H), 1.63–1.48 (m, 4H), 1.41 (m, 1H), 0.93–0.85 (m, 25H), 0.09 (s, 6H), 0.08 (s, 3H), 0.07 (s, 3H), 0.06 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 170.4, 84.6, 77.1, 75.9, 71.6, 63.3, 52.8, 42.8, 36.0, 31.2, 31.0, 26.5, 26.1, 25.8, 20.8, 18.5, 18.2, 14.2, 11.2, −3.6, −3.7, −3.9, −4.2; MS (ESI) m/z 537 [M + Na]+; HRMS (ESI, QSTAR-TOF) calcd for C27H54O5Si2Na [M + Na]+ 537.3402, found 537.3391.
R f = 0.7 (SiO2, 20% EtOAc in petroleum ether); [α]24D = +5.11 (c 0.90, CHCl3); IR νmax 3564, 2925, 2856, 2362, 2333, 1741, 1531, 1462, 1250, 1053, 835, 773, 671 cm−1; 1H NMR (300 MHz, CDCl3): δ 5.74 (t, J = 6.5 Hz, 1H), 4.80 (q, J = 13.8 Hz, 2H), 3.86 (q, J = 5.1 Hz, 1H), 3.62 (t, J = 6.8 Hz, 2H), 3.55 (d, J = 6.6 Hz, 1H), 2.34–2.30 (m, 2H), 2.07 (s, 3H), 1.71–1.29 (m, 6H), 0.91–0.84 (m, 52H), 0.07 (s, 3H), 0.06 (s, 3H), 0.04 (s, 3H), 0.02 (s, 3H); 13C NMR (75 MHz, CDCl3): δ 170.9, 140.6, 137.5, 76.0, 72.6, 67.0, 63.2, 43.0, 35.6, 31.9, 31.6, 29.1, 27.4, 26.2, 25.9, 22.7, 21.0, 18.5, 18.2, 14.1, 13.7, 11.2, 10.0, −3.4(2), −3.9, −4.0; MS (ESI) m/z 807 [M + H]+, 829 [M + Na]+; HRMS (ESI, QSTAR-TOF) calcd for C39H82O5Si2SnNa [M + Na]+ 829.4615, found 829.4613.
To the above mesylated compound dissolved in dry THF (40 mL) was added NaI (3.41 g, 22.72 mmol) at room temperature and stirred for 3 h. Then the reaction mixture was filtered through a short pad of silica and concentrated in vacuo. The iodo compound (Rf = 0.45, 10% EtOAc in petroleum ether) was used directly for next step without any further purification.
To a stirred solution of (R)-4-benzyl-3-propionyloxazolidin-2-one (7.07 g, 30.3 mmol) in THF (60 mL) was added NaHMDS (1 M in THF, 30.3 mL, 30.3 mmol) at −78 °C. The resulting dark yellow coloured solution was stirred for 1 h at −78 °C. Then the iodo compound dissolved in THF (10 mL, ×2) was cannulated to the above reaction mixture and stirred for 2 h at −78 °C and 12 h at −40 °C. It was then quenched by adding saturated NH4Cl (20 mL) and extracted with EtOAc (2 × 100 mL). The organic extracts were washed with water (20 mL), brine (20 mL), dried (Na2SO4), filtered and concentrated in vacuo. Purification of the crude product by column chromatography (SiO2, 10% EtOAc in the petroleum ether eluent) furnished 24 (3.19 g, 51% over three steps) as a colourless liquid.
R f = 0.4 (SiO2, 20% EtOAc in petroleum ether); [α]24D = −25.66 (c 0.6, CHCl3); IR νmax 2922, 2852, 2322, 1775, 1694, 1453, 1383, 1273, 1237, 1208, 1102, 1014, 970, 760, 745, 700 cm−1; 1H NMR (300 MHz, CDCl3): δ 7.30–7.29 (m, 2H), 7.28–7.27 (m, 1H), 7.20–7.19 (m, 2H), 6.0 (d, J = 0.6 Hz, 1H), 4.64 (m, 1H), 4.22–4.15 (m, 2H), 4.05 (m, 1H), 3.25 (dd, J = 13.6, 3.0 Hz, 1H), 2.76–2.70 (m, 2H), 2.26 (dd, J = 12.8, 7.6 Hz, 1H), 1.91 (s, 3H), 1.15 (d, J = 6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 176.2, 153.1, 145.2, 135.2, 129.4, 129.0, 127.3, 77.4, 66.0, 55.2, 43.3, 38.0, 35.7, 23.7, 16.6; MS (ESI) m/z 436 [M + Na]+; HRMS (ESI, QSTAR-TOF) calcd for C17H20INO3Na [M + Na]+ 436.0380, found 436.0389.
Alcohol 10 (1.2 g, 5.0 mmol) was subjected to DMP mediated oxidation under similar experimental conditions as stated earlier to give an aldehyde (Rf = 0.7, 10% EtOAc in petroleum ether), which was used for the next step after passing through a short pad of column.
To a solution of phosphonate, CH3O2CCH2P(O)(OCH2CF3)2 (1.17 mL, 5.5 mmol) in THF (15 mL) at 0 °C, NaH (60% dispersion in oil, 179 mg, 4.5 mmol) was added and stirred for 40 min. The reaction mixture was then cooled to −78 °C and the above aldehyde, dissolved in THF (5 mL, ×2) was cannulated, stirred at this temperature for 6 h and slowly warmed to 0 °C. It was then quenched with saturated aqueous NH4Cl (10 mL) and extracted with EtOAc (2 × 75 mL). The combined organic extracts were washed with water (15 mL), brine (15 mL), dried (Na2SO4), filtered and concentrated in vacuo. Purification of the crude product by column chromatography (SiO2, 5% EtOAc in the petroleum ether eluent) afforded the pure compound 25 (1.175 g, 80%) as a colourless liquid.
R f = 0.6 (SiO2, 10% EtOAc in petroleum ether); [α]28D = −69.65 (c 0.72, CHCl3); IR νmax 2922, 2853, 1723, 1646, 1516, 1462, 1202, 1176, 822, 670 cm−1; 1H NMR (300 MHz, CDCl3): δ 5.97–5.87 (m, 2H), 5.72 (d, J = 12.0 Hz, 1H), 3.77 (m, 1H), 3.70 (s, 3H), 2.22–2.19 (m, 2H), 1.83 (d, J = 1.5 Hz, 3H), 0.97 (d, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 166.5, 154.7, 146.0, 118.4, 76.0, 51.1, 46.7, 30.8, 23.7, 19.7; Anal. Calcd for C10H15IO2: C, 40.83; H, 5.14. Found: C, 41.19; H, 5.54.
R f = 0.4 (SiO2, 20% EtOAc in petroleum ether); [α]24D = −31.9 (c 0.50, CHCl3); IR νmax 3565, 2922, 2854, 2362, 2333, 1741, 1706, 1516, 1036, 669 cm−1; 1H NMR (500 MHz, CDCl3): δ 5.85 (s, 1H), 5.56 (m, 1H), 5.26 (t, J = 10.1 Hz, 1H), 4.14 (d, J = 6.7 Hz, 2H), 2.66 (m, 1H), 2.22–2.11 (m, 2H), 1.82 (s, 3H), 1.20 (br s, 1H), 0.95 (d, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 146.1, 137.7, 127.7, 76.1, 58.7, 47.2, 30.6, 24.0, 20.8; Anal. Calcd for C9H15IO: C, 40.62; H, 5.68. Found: C, 41.33; H, 5.94.
To a stirred solution of (S)-4-benzyl-3-propionyloxazolidin-2-one (565 mg, 2.42 mmol) in dry EtOAc (5 mL) was added MgCl2 (46 mg, 0.48 mmol) followed by Et3N (4.5 mL, 32.32 mmol) at room temperature under a nitrogen atmosphere. Then the aldehyde dissolved in EtOAc (3 mL, ×2) was added via a cannula, followed by TMS-Cl (3.08 mL, 24.24 mmol). After stirring for 24 h at room temperature the reaction mixture was filtered through a short pad of silica and the silica bed was washed with EtOAc (20 mL). Combined filtrate and washings were concentrated under reduced pressure. The residual oil was dissolved in MeOH (10 mL) and treated with TFA (1 drop) and stirred for 30 min. The solvent was removed under reduced pressure. Purification of the crude product by column chromatography (SiO2, 10–15% EtOAc in the petroleum ether eluent) provided aldol compound 27 (578 mg, 72%) as yellow liquid.
R f = 0.4 (SiO2, 20% EtOAc in petroleum ether); [α]26D = +6.30 (c 1.00, CHCl3); IR νmax 3565, 2963, 2924, 2362, 2333, 1778, 1705, 1647, 1485, 1388, 1211, 1008, 754, 700 cm−1; 1H NMR (500 MHz, CDCl3): δ 7.34–7.24 (m, 5H), 5.88 (m, 1H), 5.41–5.33 (m, 2H), 4.71 (m, 1H), 4.53 (t, J = 8.4 Hz, 1H), 4.22–4.16 (m, 2H), 3.91 (m, 1H), 3.33 (dd, J = 13.6, 3.3 Hz, 1H), 2.82 (dd, J = 13.6, 9.3 Hz, 1H), 2.78 (m, 1H), 2.21 (d, J = 7.5 Hz, 2H), 1.85 (d, J = 0.9 Hz, 3H), 1.13 (d, J = 6.8 Hz, 3H), 0.95 (d, J = 6.7 Hz, 3H); 13C NMR (75 MHz, CDCl3): δ 176.3, 153.5, 146.2, 139.2, 135.2, 129.5, 129.0, 128.9, 127.3, 76.2, 70.8, 66.0, 55.5, 47.3, 43.6, 37.7, 30.8, 24.0, 20.5, 14.5; MS (ESI) m/z 520 [M + Na]+; HRMS (ESI, QSTAR-TOF) calcd for C22H28IO4NNa [M + Na]+ 520.0955, found 520.0949.
To a solution of the above TBS protected compound in a mixture of THF and water (5:1) (5 mL) was added NaBH4 (194 mg, 5.13 mmol) at 0 °C. The reaction mixture was allowed to attain room temperature and stirred overnight. Then the reaction mixture was quenched by the addition of saturated aqueous NH4Cl (5 mL) at 0 °C. The solvent was removed by rotary evaporation and the resulting residual oil was extracted with EtOAc (2 × 10 mL). The combined organic layers were washed with water (5 mL), saturated aqueous NaCl (5 mL), dried (Na2SO4), filtered and concentrated under vacuum. Purification by column chromatography (silica gel, 10% EtOAc in the petroleum ether eluent) afforded pure compound 9 (332 mg, 74% over two steps) as light yellow oil.
R f = 0.65 (SiO2, 20% EtOAc in petroleum ether); [α]26D = −2.99 (c 0.30, CHCl3); IR νmax 3565, 2955, 2926, 2362, 2333, 1694, 1647, 1516, 1463, 1253, 1071, 1029, 838, 778, 673 cm−1; 1H NMR (500 MHz, CDCl3): δ 5.91 (s, 1H), 5.41 (dd, J = 11.3, 8.3 Hz, 1H), 5.19 (t, J = 10.6 Hz, 1H), 4.41 (dd, J = 8.5, 5.6 Hz, 1H), 3.81 (m, 1H), 3.57 (m, 1H), 2.76 (m, 1H), 2.57 (m, 1H), 2.25 (dd, J = 13.4, 5.4 Hz, 1H), 2.10 (dd, J = 13.6, 9.0 Hz, 1H), 1.83 (s, 3H), 0.98 (d, J = 6.8 Hz, 3H), 0.88 (brs, 12H), 0.09 (s, 3H), 0.05 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 145.7, 135.2, 131.4, 76.5, 74.1, 65.7, 47.0, 41.7, 30.6, 25.8, 23.9, 20.1, 18.0, 14.3, −3.9, −4.9; MS (ESI) m/z 461 [M + Na]+; HRMS (ESI, QSTAR-TOF) calcd for C18H35IO2SiNa [M + Na]+ 461.1343, found 461.1349.
R f = 0.5 (SiO2, 2% EtOAc in petroleum ether); [α]28D = +4.13 (c 0.63, CHCl3); IR νmax 2927, 2856, 2363, 2332, 1690, 1627, 1516, 1462, 1180, 1029, 866, 775 cm−1; 1H NMR (500 MHz, CDCl3): δ 6.23 (t, J = 10.5 Hz, 1H), 5.89 (s, 1H), 5.78 (d, J = 11.9 Hz, 1H), 5.25 (dd, J = 10.9, 8.9 Hz, 1H), 5.12 (m, 1H), 4.35 (dd, J = 8.9, 4.0 Hz, 1H), 3.68 (s, 3H), 3.57 (m, 1H), 2.58 (m, 1H), 2.22 (dd, J = 13.0, 6.0 Hz, 1H), 2.10 (dd, J = 13.0, 8.0 Hz, 1H), 1.83 (s, 3H), 1.05 (d, J = 7.0 Hz, 3H), 0.88 (brs, 12H), 0.07 (s, 3H), 0.03 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 166.6, 152.0, 146.0, 134.8, 131.2, 119.1, 76.3, 71.9, 51.0, 47.1, 40.2, 30.7, 25.8, 23.9, 20.2, 18.1, 16.6, −4.0, −4.8; MS (ESI) m/z 515 [M + Na]+; HRMS (ESI, QSTAR-TOF) calcd for C21H37IO3SiNa [M + Na]+ 515.1448, found 515.1453.
R f = 0.5 (SiO2, 40% EtOAc in petroleum ether); [α]28D = +21.05 (c 0.47, CHCl3); IR νmax 2921, 2853, 2363, 2332, 1685, 1516, 1461, 1229, 1009, 812 cm−1; 1H NMR (500 MHz, CDCl3): δ 6.68 (dd, J = 10.1, 2.0 Hz, 1H), 5.99 (dd, J = 10.1, 2.0 Hz, 1H), 5.92 (s, 1H), 5.52 (dd, J = 11.2, 10.2 Hz, 1H), 5.43 (dd, J = 11.2, 9.1 Hz, 1H), 4.77 (dd, J = 10.1, 9.1 Hz, 1H), 2.69 (m, 1H), 2.50 (m, 1H), 2.28 (dd, J = 13.2, 6.1 Hz, 1H), 2.16 (dd, J = 13.2, 8.1 Hz, 1H), 1.83 (s, 3H), 1.09 (d, J = 7.1 Hz, 3H), 0.93 (d, J = 7.1 Hz, 3H); 13C NMR (125 MHz, CDCl3): δ 163.8, 150.9, 145.7, 141.8, 124.6, 120.5, 79.2, 76.5, 46.9, 33.8, 30.7, 23.8, 20.0, 15.9; MS (ESI) m/z 347 [M + H]+, 369 [M + Na]+; HRMS (ESI, QSTAR-TOF) calcd for C14H19IO2Na [M + Na]+ 369.0321, found 369.0324.
R f = 0.3 (SiO2, 40% EtOAc in petroleum ether); [α]26D = +37.90 (c 0.29, CHCl3); IR νmax 3619, 2926, 2856, 2362, 2333, 1737, 1546, 1463, 1250, 1055, 1021, 835, 773, 671 cm−1; 1H NMR (600 MHz, CDCl3): δ 6.69 (dd, J = 9.8, 2.2 Hz, 1H), 5.99 (dd, J = 9.8, 2.4 Hz, 1H), 5.61 (d, J = 1.3 Hz, 1H), 5.54 (t, J = 10.7 Hz, 1H), 5.53 (t, J = 6.7 Hz, 1H), 5.38 (dd, J = 10.7, 10.0 Hz, 1H), 4.80 (t, J = 10 Hz, 1H), 4.65 (d, J = 12.5 Hz, 1H), 4.56 (d, J = 12.5 Hz, 1H), 3.86 (m, 1H), 3.62 (m, 2H), 3.56 (dd, J = 6.8, 1.8 Hz, 1H), 2.67 (ddqd, J = 10.7, 8.6, 7.0, 6.0 Hz, 1H), 2.50 (dqt, J = 10.0, 7.0, 2.5 Hz, 1H), 2.40 (m, 2H), 2.15 (dd, J = 13.5, 6.0 Hz, 1H), 2.03 (s, 3H), 1.95 (dd, J = 13.5, 8.6 Hz, 1H), 1.72 (d, J = 1.3 Hz, 3H), 1.68–1.51 (m, 4H), 1.38 (m, 1H), 1.24 (m, 1H), 1.09 (d, J = 7.3 Hz, 3H), 0.90 (d, J = 6.5 Hz, 3H), 0.88–0.86 (m, 18H), 0.85 (d, J = 6.9 Hz, 3H), 0.84 (d, J = 6.7 Hz, 3H), 0.07–0.06 (s, 6H), 0.03–0.02 (s, 6H); 13C NMR (125 MHz, CDCl3): δ 171.1, 163.9, 150.9, 142.8, 135.9, 132.8, 130.5, 127.1, 123.9, 120.5, 79.3, 76.3, 72.7, 63.2, 62.6, 47.8, 42.9, 35.7, 34.3, 33.8, 31.4, 31.0, 30.7, 26.1, 25.9, 21.0, 19.8, 18.5, 18.2, 17.9, 15.9, 14.1, 10.9, −3.4, −3.5, −4.0, −4.1; MS (ESI) m/z 735 [M + H]+, 757 [M + Na]+; HRMS (ESI, QSTAR-TOF) calcd for C41H74O7Si2Na [M + Na]+ 757.4865, found 757.4859.
R f = 0.8 (SiO2, 40% EtOAc in petroleum ether); [α]26D = +12.75 (c 0.4, CHCl3); IR νmax 3743, 2921, 2851, 1740, 1550, 1464, 1219, 772 cm−1; 1H NMR (500 MHz, CDCl3): δ 6.68 (dd, J = 9.7, 2.3 Hz, 1H), 5.99 (dd, J = 9.7, 2.4 Hz, 1H), 5.61 (s, 1H), 5.54 (t, J = 10.7 Hz, 1H), 5.49 (t, J = 7.3 Hz, 1H), 5.39 (dd, J = 10.3, 9.9 Hz, 1H), 4.80 (m, 1H), 4.66 (d, J = 12.0 Hz, 1H), 4.56 (d, J = 12.0 Hz, 1H), 3.92 (m, 1H), 3.66 (s, 3H), 3.57 (dd, J = 7.1, 0.6 Hz, 1H), 2.67 (m, 1H), 2.50 (dqt, J = 10.0, 7.0, 2.5 Hz, 1H), 2.41 (t, J = 6.8 Hz, 2H), 2.38–2.23 (m, 4H), 2.15 (dd, J = 13.0, 5.8 Hz, 1H), 2.03 (s, 3H), 1.95 (dd, J = 13.0, 8.5 Hz, 1H), 1.72 (d, J = 1.0 Hz, 3H), 1.10 (d, J = 7.3 Hz, 3H), 0.91 (d, J = 5.0 Hz, 3H), 0.90–0.86 (m, 20H), 0.85–0.80 (m, 6H), 0.08–0.07 (m, 6H), 0.06 (s, 3H), 0.05 (s, 3H); 13C NMR (125 MHz, CDCl3): δ 174.2, 170.9, 163.8, 150.8, 142.7, 135.9, 133.0, 130.3, 127.2, 124.0, 120.5, 79.3, 72.4, 62.5, 51.5, 47.8, 42.5, 35.3, 34.3, 33.8, 32.3, 31.9, 30.7, 30.5, 26.2, 25.9, 21.0, 19.7, 18.5, 18.2, 17.9, 15.9, 13.2, 10.3, −3.3, −3.4, −3.9, −4.0; MS (ESI) m/z 785 [M + Na]+; HRMS (ESI, QSTAR-TOF) calcd for C42H74O8Si2Na [M + Na]+ 785.4814, found 785.4812.
Footnote |
† Electronic supplementary information (ESI) available: The copies of 1H and 13C NMR spectra for compounds 13–19, 7, 20–28, 9, 6, 29 and 30. See DOI: 10.1039/c4ob01716a |
This journal is © The Royal Society of Chemistry 2015 |